nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—Aplastic anaemia—Auranofin—psoriatic arthritis	0.0627	0.0627	CcSEcCtD
Tolazamide—Pancytopenia—Auranofin—psoriatic arthritis	0.0398	0.0398	CcSEcCtD
Tolazamide—Reaction gastrointestinal—Methotrexate—psoriatic arthritis	0.0388	0.0388	CcSEcCtD
Tolazamide—Agranulocytosis—Auranofin—psoriatic arthritis	0.0349	0.0349	CcSEcCtD
Tolazamide—Leukopenia—Auranofin—psoriatic arthritis	0.0261	0.0261	CcSEcCtD
Tolazamide—Thrombocytopenia—Auranofin—psoriatic arthritis	0.0233	0.0233	CcSEcCtD
Tolazamide—Eruption—Methotrexate—psoriatic arthritis	0.021	0.021	CcSEcCtD
Tolazamide—Dyspepsia—Auranofin—psoriatic arthritis	0.021	0.021	CcSEcCtD
Tolazamide—Urticaria—Auranofin—psoriatic arthritis	0.0189	0.0189	CcSEcCtD
Tolazamide—Pruritus—Auranofin—psoriatic arthritis	0.0169	0.0169	CcSEcCtD
Tolazamide—Rash—Auranofin—psoriatic arthritis	0.015	0.015	CcSEcCtD
Tolazamide—Nausea—Auranofin—psoriatic arthritis	0.0142	0.0142	CcSEcCtD
Tolazamide—Abdominal distension—Prednisolone—psoriatic arthritis	0.0135	0.0135	CcSEcCtD
Tolazamide—Abdominal distension—Triamcinolone—psoriatic arthritis	0.0124	0.0124	CcSEcCtD
Tolazamide—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.0123	0.0123	CcSEcCtD
Tolazamide—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.0121	0.0121	CcSEcCtD
Tolazamide—Abdominal distension—Prednisone—psoriatic arthritis	0.00978	0.00978	CcSEcCtD
Tolazamide—Erythema—Prednisolone—psoriatic arthritis	0.00931	0.00931	CcSEcCtD
Tolazamide—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00864	0.00864	CcSEcCtD
Tolazamide—Erythema—Triamcinolone—psoriatic arthritis	0.00856	0.00856	CcSEcCtD
Tolazamide—Erythema—Methylprednisolone—psoriatic arthritis	0.00855	0.00855	CcSEcCtD
Tolazamide—Malaise—Prednisolone—psoriatic arthritis	0.0084	0.0084	CcSEcCtD
Tolazamide—Vertigo—Prednisolone—psoriatic arthritis	0.00837	0.00837	CcSEcCtD
Tolazamide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00795	0.00795	CcSEcCtD
Tolazamide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00793	0.00793	CcSEcCtD
Tolazamide—Discomfort—Prednisolone—psoriatic arthritis	0.00783	0.00783	CcSEcCtD
Tolazamide—Erythema—Betamethasone—psoriatic arthritis	0.00777	0.00777	CcSEcCtD
Tolazamide—Erythema—Dexamethasone—psoriatic arthritis	0.00777	0.00777	CcSEcCtD
Tolazamide—Malaise—Triamcinolone—psoriatic arthritis	0.00772	0.00772	CcSEcCtD
Tolazamide—Pancytopenia—Methotrexate—psoriatic arthritis	0.00771	0.00771	CcSEcCtD
Tolazamide—Malaise—Methylprednisolone—psoriatic arthritis	0.00771	0.00771	CcSEcCtD
Tolazamide—Vertigo—Triamcinolone—psoriatic arthritis	0.0077	0.0077	CcSEcCtD
Tolazamide—Vertigo—Methylprednisolone—psoriatic arthritis	0.00768	0.00768	CcSEcCtD
Tolazamide—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00741	0.00741	CcSEcCtD
Tolazamide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00721	0.00721	CcSEcCtD
Tolazamide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00721	0.00721	CcSEcCtD
Tolazamide—Discomfort—Triamcinolone—psoriatic arthritis	0.0072	0.0072	CcSEcCtD
Tolazamide—Discomfort—Methylprednisolone—psoriatic arthritis	0.00719	0.00719	CcSEcCtD
Tolazamide—Malaise—Dexamethasone—psoriatic arthritis	0.00701	0.00701	CcSEcCtD
Tolazamide—Malaise—Betamethasone—psoriatic arthritis	0.00701	0.00701	CcSEcCtD
Tolazamide—Vertigo—Betamethasone—psoriatic arthritis	0.00698	0.00698	CcSEcCtD
Tolazamide—Vertigo—Dexamethasone—psoriatic arthritis	0.00698	0.00698	CcSEcCtD
Tolazamide—Erythema—Prednisone—psoriatic arthritis	0.00677	0.00677	CcSEcCtD
Tolazamide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00675	0.00675	CcSEcCtD
Tolazamide—Discomfort—Betamethasone—psoriatic arthritis	0.00654	0.00654	CcSEcCtD
Tolazamide—Discomfort—Dexamethasone—psoriatic arthritis	0.00654	0.00654	CcSEcCtD
Tolazamide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00628	0.00628	CcSEcCtD
Tolazamide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00626	0.00626	CcSEcCtD
Tolazamide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00621	0.00621	CcSEcCtD
Tolazamide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00621	0.00621	CcSEcCtD
Tolazamide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00615	0.00615	CcSEcCtD
Tolazamide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00614	0.00614	CcSEcCtD
Tolazamide—Malaise—Prednisone—psoriatic arthritis	0.0061	0.0061	CcSEcCtD
Tolazamide—Vertigo—Prednisone—psoriatic arthritis	0.00608	0.00608	CcSEcCtD
Tolazamide—Urticaria—Prednisolone—psoriatic arthritis	0.00604	0.00604	CcSEcCtD
Tolazamide—Fatigue—Triamcinolone—psoriatic arthritis	0.00603	0.00603	CcSEcCtD
Tolazamide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00601	0.00601	CcSEcCtD
Tolazamide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00576	0.00576	CcSEcCtD
Tolazamide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00575	0.00575	CcSEcCtD
Tolazamide—Discomfort—Prednisone—psoriatic arthritis	0.00569	0.00569	CcSEcCtD
Tolazamide—Erythema—Methotrexate—psoriatic arthritis	0.00566	0.00566	CcSEcCtD
Tolazamide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00558	0.00558	CcSEcCtD
Tolazamide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00558	0.00558	CcSEcCtD
Tolazamide—Urticaria—Triamcinolone—psoriatic arthritis	0.00555	0.00555	CcSEcCtD
Tolazamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00554	0.00554	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00548	0.00548	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00548	0.00548	CcSEcCtD
Tolazamide—Fatigue—Betamethasone—psoriatic arthritis	0.00547	0.00547	CcSEcCtD
Tolazamide—Fatigue—Dexamethasone—psoriatic arthritis	0.00547	0.00547	CcSEcCtD
Tolazamide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00525	0.00525	CcSEcCtD
Tolazamide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00523	0.00523	CcSEcCtD
Tolazamide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00523	0.00523	CcSEcCtD
Tolazamide—Malaise—Methotrexate—psoriatic arthritis	0.0051	0.0051	CcSEcCtD
Tolazamide—Vertigo—Methotrexate—psoriatic arthritis	0.00508	0.00508	CcSEcCtD
Tolazamide—Leukopenia—Methotrexate—psoriatic arthritis	0.00506	0.00506	CcSEcCtD
Tolazamide—Urticaria—Betamethasone—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Tolazamide—Urticaria—Dexamethasone—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Tolazamide—Dizziness—Prednisolone—psoriatic arthritis	0.00503	0.00503	CcSEcCtD
Tolazamide—Asthenia—Triamcinolone—psoriatic arthritis	0.00502	0.00502	CcSEcCtD
Tolazamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.005	0.005	CcSEcCtD
Tolazamide—Pruritus—Triamcinolone—psoriatic arthritis	0.00495	0.00495	CcSEcCtD
Tolazamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.00493	0.00493	CcSEcCtD
Tolazamide—Dyspepsia—Prednisone—psoriatic arthritis	0.00486	0.00486	CcSEcCtD
Tolazamide—Rash—Prednisolone—psoriatic arthritis	0.00479	0.00479	CcSEcCtD
Tolazamide—Fatigue—Prednisone—psoriatic arthritis	0.00476	0.00476	CcSEcCtD
Tolazamide—Headache—Prednisolone—psoriatic arthritis	0.00476	0.00476	CcSEcCtD
Tolazamide—Discomfort—Methotrexate—psoriatic arthritis	0.00476	0.00476	CcSEcCtD
Tolazamide—Dizziness—Triamcinolone—psoriatic arthritis	0.00462	0.00462	CcSEcCtD
Tolazamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.00461	0.00461	CcSEcCtD
Tolazamide—Feeling abnormal—Prednisone—psoriatic arthritis	0.00455	0.00455	CcSEcCtD
Tolazamide—Asthenia—Dexamethasone—psoriatic arthritis	0.00455	0.00455	CcSEcCtD
Tolazamide—Asthenia—Betamethasone—psoriatic arthritis	0.00455	0.00455	CcSEcCtD
Tolazamide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00452	0.00452	CcSEcCtD
Tolazamide—Nausea—Prednisolone—psoriatic arthritis	0.00451	0.00451	CcSEcCtD
Tolazamide—Pruritus—Betamethasone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Tolazamide—Pruritus—Dexamethasone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Tolazamide—Rash—Triamcinolone—psoriatic arthritis	0.00441	0.00441	CcSEcCtD
Tolazamide—Rash—Methylprednisolone—psoriatic arthritis	0.0044	0.0044	CcSEcCtD
Tolazamide—Urticaria—Prednisone—psoriatic arthritis	0.00439	0.00439	CcSEcCtD
Tolazamide—Headache—Triamcinolone—psoriatic arthritis	0.00438	0.00438	CcSEcCtD
Tolazamide—Headache—Methylprednisolone—psoriatic arthritis	0.00437	0.00437	CcSEcCtD
Tolazamide—Dizziness—Dexamethasone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Tolazamide—Dizziness—Betamethasone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Tolazamide—Nausea—Triamcinolone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Tolazamide—Nausea—Methylprednisolone—psoriatic arthritis	0.00414	0.00414	CcSEcCtD
Tolazamide—Dyspepsia—Methotrexate—psoriatic arthritis	0.00406	0.00406	CcSEcCtD
Tolazamide—Rash—Betamethasone—psoriatic arthritis	0.004	0.004	CcSEcCtD
Tolazamide—Rash—Dexamethasone—psoriatic arthritis	0.004	0.004	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00399	0.00399	CcSEcCtD
Tolazamide—Fatigue—Methotrexate—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Tolazamide—Headache—Betamethasone—psoriatic arthritis	0.00397	0.00397	CcSEcCtD
Tolazamide—Headache—Dexamethasone—psoriatic arthritis	0.00397	0.00397	CcSEcCtD
Tolazamide—Asthenia—Prednisone—psoriatic arthritis	0.00396	0.00396	CcSEcCtD
Tolazamide—Pruritus—Prednisone—psoriatic arthritis	0.00391	0.00391	CcSEcCtD
Tolazamide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.0038	0.0038	CcSEcCtD
Tolazamide—Nausea—Dexamethasone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Tolazamide—Nausea—Betamethasone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Tolazamide—Urticaria—Methotrexate—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Tolazamide—Dizziness—Prednisone—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Tolazamide—Rash—Prednisone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Tolazamide—Headache—Prednisone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Tolazamide—Asthenia—Methotrexate—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Tolazamide—Nausea—Prednisone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Tolazamide—Pruritus—Methotrexate—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Tolazamide—Dizziness—Methotrexate—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Tolazamide—Rash—Methotrexate—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Tolazamide—Headache—Methotrexate—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Tolazamide—Nausea—Methotrexate—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
